1Baig NA,Herrine SK,Rubin R.Liver disease and diabetes mellitus.Clin Lab Med,2001;21(1):193～207
2Melter AA,Everhart JE.Association between diabetes and serum alaine aminotransferase activity among Mexican Americans.Am J Epidemiol,1997;146(7)∶565～571
3Younossi ZM,Grramlich T,Liu YC,et al.Nonalcoholic fatty liver disease:assessment of variability in pathologic interpretations.Mod Pathol,1998;11;560～565
4Younossi Z,Matteoni C,Gramlich T,et al.Patients characteristics predicting cirrhosis and death in nonalcoholic liver disease.Hepatology,1998;28:303A
5Anguol P,Keach JC,Batts KP,et al.Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitisHepatology,1999;30:1356～1362
6Menon KVN,Angulo P,Lindor KD.Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.Am J Gastroenterol,2001;96(5):1631～1634
7Turlin B,Mendler MH,Moirand R,et al.Histologic features of the liver in insulin resistance-associated iron overload:A study of 139 patients.Am J Clin Pathol,2001;116(2):263～270
8Matteoni.Outcomes in nonalcoholic fatty liver disease.Gastroenterology,2000,116;1415～1419
9Mc Cullough,Arthur J.Update on nonalcoholic fatty liver disease.J Clin Gastroenterol,2002;34(3):255
10Marchesini G,Brizi M,Bianchi G,et al.Nonalcoholic fatty liver disease:a feature of the metabolic syndrome.Diabetes,2001;50(8):1844～1850
